Opinion
2011-1334 2011-1335 2011-1336
08-26-2011
AVENTIS PHARMACEUTICALS INC.,Plaintiff-Appellant, AND AMR TECHNOLOGY, INC. (NOW KNOWN AS ALBANY MOLECULAR RESEARCH, INC.), Plaintiff-Appellant, v. DR. REDDY'S LABORATORIES, LTD. AND DR. REDDY'S LABORATORIES, INC., Defendants-Appellees. AVENTIS PHARMACEUTICALS INC., Plaintiff-Appellant, AND AMR TECHNOLOGY, INC. (NOW KNOWN AS ALBANY MOLECULAR RESEARCH, INC.), Plaintiff-Appellant, v. AMINO CHEMICALS LTD., DIPHARMA FRANCIS, SR.L., AND DIPHARMA SPA, Defendants-Appellees, AND MYLAN PHARMACEUTICALS INC., Defendant. AVENTIS PHARMACEUTICALS INC., Plaintiff-Appellant, AND AMR TECHNOLOGY, INC. (NOW KNOWN AS ALBANY MOLECULAR RESEARCH, INC.), Plaintiff-Appellant, v. TEVA PHARMACEUTICALS USA, INC., Defendant-Appellee, AND AMINO CHEMICALS LTD., DIPHARMA FRANCIS, SR.L., AND DIPHARMA SPA, Defendants-Appellees.
NOTE: This order is nonprecedential.
Appeals from the United States District Court for the District of New Jersey in case nos. 04-CV-1075, 04-CV-1077, and 04-CV-1078, Chief Judge Garrett E. Brown, Jr.
ON MOTION
ORDER
Upon consideration of Aventis Pharmaceuticals, Inc.'s motion to voluntarily dismiss this appeal as to Mylan Pharmaceuticals, Inc. due to settlement,
IT IS ORDERED THAT:
The motion is granted to the extent that the revised official caption is reflected above to indicate that Mylan is no longer an appellee.
FOR THE COURT
Jan Horbaly
Clerk
cc: Andrew P. Zappia, Esq.
Paul H. Berghoff, Esq.
Anthony W. Shaw, Esq.
Michael E. Patunas, Esq
Martin B. Pavane, Esq.
E. Anthony Figg, Esq.